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Tramm R, McCarthy A, Yates P 
Title: Dietary modification for women after breast cancer treatment: A narrative 
review 
Abstract 
Diet is thought to account for about 25% of cancers in developed countries. It is well-
documented that the risks associated with both the breast cancer itself and its 
treatments are important for women previously treated for breast cancer. Women are 
at risk of recurrence of the primary disease and prone to develop treatment-induced 
comorbidities, some of which are thought to be modified by diet. With a view to 
making dietary recommendations for the breast cancer patients we encounter in our 
clinical nursing research, we mined the literature to scope the most current robust 
evidence concerning the role of the diet in protecting women against the recurrence of 
breast cancer and its potential to ameliorate some of the longer-term morbidities 
associated with the disease. We found that the evidence about the role of the diet in 
breast cancer recurrence is largely inconclusive. However, drawing on international 
guidelines enabled us to make three definitive recommendations: women at risk of 
breast cancer recurrence, or who experience co-morbidities as a result of treatment, 
should limit their exposure to alcohol; moderate their nutritional intake so it does not 
contribute to post-menopausal weight gain; and should adhere to a balanced diet. 
Nursing education planned for breast cancer patients about dietary issues should 
ideally be individually-tailored, based on a good understanding of the international 
recommendations and the evidence underpinning them. 
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Introduction 
With approximately 10 million new cases reported internationally each year, cancer is 
a significant health problem (Parkin et al., 2005). Due to advances in early detection 
and treatment, 66% of people diagnosed with cancer in Western countries are now 
expected to be alive five years after diagnosis (Jemal et al., 2009). Within the last 
decade women treated for breast cancer represent the majority (27%) of this growing 
group (Parkin and Fernandez, 2006, Jemal et al., 2009). Due to these encouraging 
developments in mortality rates, while breast cancer is still not considered curable it is 
now often conceptualised as a ‘chronic’ disease (Eakin et al., 2006).  
An emergent discourse in Western countries is the potential for breast cancer 
chronicity to become a significant public health issue. This concern arises from the 
well-documented risks associated with both the breast cancer itself and its treatments. 
Women previously treated for breast cancer have, for example, an increased risk of 
recurrence of the primary disease (Tolaney and Winer, 2007); the development of 
second primary cancers (Mellemkjaer et al., 2006); and a propensity to develop 
treatment-induced comorbidities in a variety of organ systems (Carver et al., 2007, 
Eakin et al., 2006, Gupta et al., 2006, Hooning et al., 2006, Maxwell and Viale, 2005, 
Yeh et al., 2004). These adverse outcomes threaten the quality of life and health of the 
individual after breast cancer treatment. Many of these outcomes are, however, 
believed to be modifiable. Hence a second theme in the discourse, related to the first, 
emphasizes the responsibility of women previously treated for breast cancer to 
observe exemplary health and lifestyle behaviours to prevent or lessen the severity of 
treatment-related morbidities (Ganz and Hahn, 2008, Jones and Demark-Wahnefried, 
2006). Women previously treated for breast cancer are now encouraged to 
consistently practise health-promotion and risk-reduction strategies such as regular 
health screening; resistance and aerobic training; and alcohol and tobacco restriction.  
A health behaviour strategy also thought to protect health after cancer treatment is 
dietary modification. It is, however, also one of the most contested in the literature 
and in clinical practice (Hankinson et al., 2004, Norman et al., 2007). The dietary 
discourse in cancer emerged from epidemiological studies, which quantified that 
women from countries with previously low breast cancer rates developed identical 
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incidence rates to their host countries within one or two generations (McCracken et 
al., 2007, Pike et al., 2002). These studies, which implicated environmental changes 
in the increased incidence of breast cancer in migrant populations, indicated that 
Westernised diets could play a significant part in the development or recurrence of the 
disease.  
Diet is now thought to account for approximately 25% of cancers in developed 
countries (Key et al., 2002); hence its role as a modifiable risk factor in the context of 
breast cancer is of increasing interest to both health professionals and lay people. 
There is considerable confusion however about the precise role of specific dietary 
components (such as fats and vitamins) in breast cancer initiation, recurrence or 
protection; and the part they play in offsetting the long-term toxicities of breast cancer 
treatments such as ovarian failure (McCullough and Giovannucci, 2004, Duncan, 
2004).  
We recently undertook a study that examined women’s experiences of cancer, their 
health practices once treatment is completed, and their educational needs with respect 
to their post-treatment health behaviours (McCarthy et al., In review-a, McCarthy et 
al., In review-b, McCarthy et al., In review-c, Tramm, 2010, Tramm et al., In review). 
This paper scopes the evidence concerning the role of diet after breast cancer 
treatment in protecting women against recurrence, and the potential of diet to 
ameliorate some of the longer-term morbidities associated with previous breast cancer 
treatment. Our aim in this paper is to present the narrative review of the evidence that 
was undertaken prepatory to the development of education programs for breast cancer 
patients in our treatment catchment area. The evidence presented in this paper is 
selected from the latest meta-analyses and systematic reviews, and explained where 
necessary with reference to other higher-quality evidence such as large 
epidemiological and case-control studies, and significant theoretical and clinical 
papers. Drawing on current international guidelines, the paper concludes with a 
discussion of current dietary recommendations for women who have completed breast 
cancer treatment and the educational implications of these for oncology nurses. 
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Individual nutrients and breast cancer  
Dietary fat  
The role of dietary fat in the recurrence of breast cancer is controversial (Greenwald 
and Dunn, 2009). Suspicion first arose when cumulative evidence from animal studies 
indicated that dietary fat might contribute to breast cancer initiation and promotion in 
some way (Fay et al., 1997). Subsequent large epidemiological studies in humans 
supported the association between fat intake and breast cancer, with early estimates of 
a 2.5-fold risk reduction for breast cancer if fat intake was reduced by 50% (Prentice 
and Sheppard, 1990). A further pooled meta-analysis of case-control and cohort 
studies appeared to confirm this relationship (Boyd et al., 1993); with a larger meta-
analysis of 45 studies (31 case-control and 14 cohort studies) concluding that a high 
fat intake increased the risk of breast cancer irrespective of whether the fats were 
saturated or unsaturated, and calculating an overall increased risk of 13% (Boyd et al., 
2003). In contrast, a meta-analysis of 8 cohort studies at approximately the same time 
detected only a modestly-increased risk, which was associated only with saturated fat 
intake (Smith-Warner et al., 2001a). Later population-based cohort studies, however, 
tended to support an inverse relationship between fat intake and breast cancer 
incidence in pre- and postmenopausal women (Prentice et al., 2006, Sieri et al., 2008, 
Wang et al., 2008). For example, Thiebaut et al. (2007) analysed a large prospective 
cohort of postmenopausal women and reported direct relationships between all 
subgroups of fat and breast cancer. However, this trend has been challenged by the 
latest published meta-analysis, which reports no overall association between animal 
fat intake and breast cancer development (Alexander et al., 2010). 
 
There are two reasons for these contradictory conclusions. First, methodological 
critiques of these studies highlight a consistent failure to control for a variety of 
confounding variables (McCullough and Giovannucci, 2004). They also argue that 
data are often ‘tainted’ by recall bias; and the accuracy and validity of the instruments 
used to collect the data is frequently challenged (Michels et al., 2007). Equally 
important, the second reason questions the precise role of fat in breast cancer 
recurrence. The problem with fats appears not to be what they contain, but what 
happens when fat intake exceeds metabolic requirements after menopause. At present, 
it is considered probable that the components of saturated and unsaturated fats are not 
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implicated in the development of breast cancer itself, although saturated fat reduction 
is clearly important in the reduction of the longer-term cardiovascular problems 
precipitated by cancer treatments containing high-dose anthracyclines (Linos and 
Willett, 2007). It is more likely that the post-menopausal weight gain arising from a 
diet rich in energy-dense foods such as fats is the real culprit (Howell and Harvie, 
2008, van den Brandt et al., 2000).  
 
The mechanisms underlying the relationship between weight gain and the recurrence 
of breast cancer in post-menopausal women are not fully understood. They are 
complex and possibly inter-related. For example, a high intake of dietary fat can result 
in the deposition of adipose tissue. Adipose tissue produces its own oestrogenic 
compounds called leptins. High levels of adipose tissue are believed to elevate 
intrinsic oestrogen levels, which can be implicated in the development of some breast 
cancers (Sugimura, 2000). However, the accumulation of adipose tissue can also lead 
to metabolic syndrome and subsequent hyperinsulinemia and therefore, promote 
tumour growth via pathways other than oestrogen exposure (Blackburn and Wang, 
2007). Irrespective of the precise aetiology, there are now convincing data that 
implicate postmenopausal weight gain arising from excess fat consumption as a risk 
factor for breast cancer. The latest report from the World Cancer Research Fund and 
American Institute of Cancer Research (WCRF/AICR) states unequivocally that 
“there is abundant and consistent epidemiological evidence that … greater body 
fatness is a cause of postmenopausal breast cancer” (World Cancer Research Fund 
and American Institute of Cancer Research (WCRF/AICR), 2010) (p. 3). Given the 
menopause-inducing nature of many breast cancer treatments, this risk factor should 
be seriously considered where women have previously been treated for breast cancer. 
 
Carbohydrates 
The potential role of carbohydrates has also been investigated in the breast cancer 
context. Earlier cohort studies seeking associations between carbohydrate intake, 
glycaemic index or glyacemic load and breast cancer incidence did not reveal strong 
associations (Cho et al., 2003, Higginbotham et al., 2004, Sieri et al., 2008). Recent 
meta-analyses of cohort studies supported these initial findings, reporting only weak 
associations between carbohydrate intake and breast cancer development (George et 
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al., 2009, Larsson et al., 2009). These findings were challenged by a similarly recent 
population-based cohort study that reported significant associations between high 
carbohydrate intake, high glycaemic load and breast cancer in premenopausal women 
younger than 50 years (Wen et al., 2009). Notably, Larrson et al. (2009) also recently 
reported associations between carbohydrate intake and the risk of oestrogen receptor-
positive breast cancer, a finding the authors argued implicates insulin in the 
development of the disease. Unfortunately, contradictory evidence collated during one 
meta-analysis of 39 case-control and cohort studies across all types of cancers only 
found significant associations between glycaemic load or glycaemic index and 
cancers of the colorectum and the endometrium (Gnagnarella et al., 2008); and even 
these findings were recently questioned by the latest meta-analysis that found no 
associations between glycaemic index, glycaemic load and colorectal cancer risk at all 
(Mulholland et al., 2009).  
 
Several reasons for these contradictory results are proposed. It could be that like fats, 
carbohydrate metabolism is implicated in complex carcinogenic processes that are not 
necessarily related to the precise components of these compounds. It is increasingly 
accepted that where breast cancer is concerned too much carbohydrate resulting in the 
deposition of fatty tissue, which leads to higher intrinsic oestrogen levels, is one 
potential culprit. A high carbohydrate load might also increase the bioavailability of 
sex hormones, which is consistently suggested as a mechanism that encourages breast 
carcinogenesis and discourages apoptosis (World Cancer Research Fund and 
American Institute of Cancer Research (WCRF/AICR), 2010). Furthermore, like fats, 
carbohydrate metabolism alters insulin levels. Carbohydrate in excess of requirements 
can result in compensatory hyperinsulinaemia and insulin resistance, which may 
promote tumour growth and also stimulate proliferative factors such as insulin-like 
growth factor (Sugimura, 2000, Longo and Fontana, 2009). 
 
Alcohol  
Alcohol is an important dietary factor to consider in this context for three reasons. 
First, it disinhibits appetite and this coupled with its high caloric density can 
contribute to unnecessary weight gain (Michels et al., 2007). This could increase the 
risk of recurrence in postmenopausal women (Kwan et al., 2010). Second, the 
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metabolites of alcohol are considered potentially carcinogenic (World Cancer 
Research Fund and American Institute of Cancer Research (WCRF/AICR), 2010). 
Third, alcohol mediates the actions of oestrogen and other proliferative factors in 
numerous ways (Dumitrescu and Shields, 2005). Hence cumulative evidence over the 
last four decades has firmly established alcohol as a risk factor for breast cancer 
(Singletary and Gapstur, 2001, Smith-Warner et al., 1998, Williams and Horm, 1977, 
Knight et al., 2009). Evidence from large pooled meta-analyses indicates there is a 7 
% increased risk of breast cancer with every 10g of alcohol consumed per day 
(Hamajima et al., 2002, Smith-Warner et al., 1998).  
Fibre 
Fibre derived from fruits, vegetables, cereals and legumes is often discussed as a 
protective dietary factor in the literature (McCullough and Giovannucci, 2004). 
Considerable attention has subsequently been directed towards the compounds found 
in cruciferous vegetables such as broccoli, which are often hypothesised to help 
reduce the risk of lung, colorectal and to a lesser extent breast cancer (Higdon et al., 
2007). In breast carcinogenesis, fibre is also thought to reduce the enterohepatic 
circulation of steroids, which results in lower overall exposure to oestrogen (Hanf and 
Gonder, 2005). Unfortunately neither hypothesis is supported by subsequent meta-
analyses (World Cancer Research Fund and American Institute of Cancer Research 
(WCRF/AICR), 2010, Key et al., 1999).  
 
As with fats and carbohydrates, however, covariates must be accounted for when 
investigating the potential risks or protectors associated with specific dietary 
components in the breast cancer context. The picture with fibre becomes more 
complex, for example, when menopausal status and tumour receptivity are taken into 
account. Although earlier large cohort trials did not describe significant associations 
between dietary fibre and breast cancer incidence in pre- or postmenopausal women 
(Willett et al., 1992, Terry et al., 2002, Smith-Warner et al., 2001b), a more recent 
large prospective cohort study clearly suggested an inverse relationship between fibre 
intake and breast cancer incidence in pre-menopausal women (Cade et al., 2007). 
Another large cohort trial documented associations between fibre intake, 
postmenopausal breast cancer risk and oestrogen/progesterone receptor status (Park et 
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al., 2009); while Suzuki et al (2009) reported significant associations in their meta-
analysis of trials between specific types of fibre intake, positive oestrogen receptor 
status and postmenopausal breast cancer incidence. They calculated a risk reduction 
of 34% for women with a high fibre intake derived from fruit sources (Suzuki et al., 
2009). 
 
Despite some indications that fibre might be protective against breast cancer, at 
present no firm conclusions can be drawn about its precise role after breast cancer 
treatment. Pooled studies to date have either provided too much low quality or 
inconsistent data, or the number of studies are too few to enable conclusions to be 
made (World Cancer Research Fund and American Institute of Cancer Research 
(WCRF/AICR), 2010). Nonetheless, it is likely that dietary fibre will remain a 
biological mechanism of interest in breast cancer recurrence. This is because it is 
known to improve insulin sensitivity and also helps counteract the weight gain 
common in treatment-induced menopause by enhancing the sensation of satiety (Hanf 
and Gonder, 2005).  
 
Micronutrients 
The oxidative stress reduction and other ‘anti-cancer’ properties of vitamins A, C and 
E have received considerable attention in the cancer literature (Lee et al., 2004, Nagel 
et al., 2010, Greenwald et al., 2007). Unfortunately, results concerning these vitamins 
are inconclusive about protective associations (World Cancer Research Fund and 
American Institute of Cancer Research (WCRF/AICR), 2010). There is similarly 
limited evidence that adequate folate and beta carotene intake could partially offset 
the risk of breast cancer in women who consume moderate to high levels of alcohol 
(World Cancer Research Fund and American Institute of Cancer Research 
(WCRF/AICR), 2010). Folate and beta carotene have antioxidant properties that mop 
up the damage caused by cellular processes and they also enhance the ability of cells 
to function properly; inadequacies of both of these activities are implicated in the 
development and recurrence of cancers (Willcox et al., 2004).  
Two other commonly-studied micronutrients are also believed to play a protective 
role in breast cancer, but their mechanism of action is not as well-hypothesised. These 
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are vitamin D and calcium. Data about the possible benefits of vitamin D first 
emerged from epidemiological studies conducted in the 1990s, which indicated 
inverse correlations between greater sun exposure at higher altitudes (implying higher 
vitamin D levels) and breast cancer incidence (Gorham et al., 1990, John et al., 1999). 
Recent meta-analyses supported this inverse relationship, reporting a 9% risk 
reduction when low and high Vitamin D intakes were compared (Chen et al., 2009). 
Chen et al (2009) also documented a 45% lower risk of breast cancer in cohorts with 
the highest levels of endogenous Vitamin D compared to cohorts with the lowest 
levels. A later case-control study, not available to Chen et al (2009), further reported 
that Vitamin D obtained from supplements was independently associated with breast 
cancer risk reduction (Anderson et al., 2010).  
 
As is common in these studies, when covariates are considered, the picture becomes 
more subtle. For example, while one meta-analysis (Gissel et al., 2008) and one 
randomised control trial of 36,282 postmenopausal women (Chlebowski et al., 2008) 
reported no associations between vitamin D intake and breast cancer development, 
when the meta-analysis was restricted to doses ≤ 400 IU daily, higher doses were 
associated with lower breast cancer incidence (Gissel et al., 2008). Significant risk 
reduction was also observed in a large randomised controlled trial of 1179 women 
when daily vitamin D doses ≥ 1100 IU (Lappe et al., 2007). Current recommendations 
for vitamin D do not exceed 400 IU per day but such cumulative evidence of 
preventive properties at higher dosages may change this threshold in the near future 
(Hines et al., 2010). There are already calls to increase the recommended vitamin D 
intake for all women to 2000 IU per day in order to reduce the estimated incidence of 
breast cancer by as much as 25% (Garland et al., 2009). Nonetheless, a 
comprehensive systematic review undertaken by the United States Agency for 
Healthcare Research and Quality classified available studies with respect to vitamin D 
as inconclusive (Chung et al., 2009); and this stance is supported by other 
international guidelines (National Health and Medical Research Council (NHMRC), 
2003, Food Standards Agency, 2010, World Cancer Research Fund and American 
Institute of Cancer Research (WCRF/AICR), 2010, Cancer Research UK, 2009). 
Concerns exist mainly because significant associations between vitamin D intake and 
breast cancer risk reduction were not evident during a follow-up period of 7 to 12 
years in either pre- or postmenopausal cohorts (Chung et al., 2009). 
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The situation is similarly confusing for calcium. In their meta-analysis of the available 
studies, Chen et al. (2009) reported a decreased overall breast cancer risk reduction of 
19% when comparing high and low quintiles of calcium intake. However, stratified 
analyses reached significance only for premenopausal women. There are also reports 
of consistent associations of breast cancer risk reduction with a daily intake of 780mg 
to 1750mg of calcium for premenopausal but not for postmenopausal women (Chung 
et al., 2009). When the role of calcium was considered in a randomised controlled 
study of 36,282 women, the authors concluded that calcium supplementation does not 
reduce invasive breast cancer incidence in postmenopausal women (Chlebowski et al., 
2008). The evidence concerning the role of calcium in breast carcinogenesis is 
therefore considered so limited and contradictory that no conclusions can reliably be 
drawn (World Cancer Research Fund and American Institute of Cancer Research 
(WCRF/AICR), 2010).  
 
Vitamin D and calcium nonetheless have significant roles to play after treatment for 
breast cancer. Recent high quality evidence indicates that women who have had breast 
cancer often have intrinsically insufficient levels of both nutrients prior to diagnosis, 
and that this deficiency carries forward after treatment (Coleman et al., 2008, Crew et 
al., 2009, Neuhouser et al., 2008). The reason for this is not currently clear, as is the 
possible role of this deficiency in the initiation or recurrence of breast cancers. 
However the importance of both of these micronutrients is unquestioned with respect 
to bone health. The cytotoxic and hormonally-active treatments used during breast 
cancer are often associated with the induction of menopause; meaning the women 
receiving them are subsequently prone to impaired bone density and osteoporotic 
fractures (Hines et al., 2010, Hillner et al., 2003). Adequate levels of vitamin D and 
calcium are recommended to lessen the risk of these adverse outcomes (National 
Health and Medical Research Council (NHMRC), 2003).  
 
Phyto-oestrogens 
Phyto-oestrogens have been extensively studied in the context of breast cancer 
prevention and recurrence. Plant-derived oestrogens are classed as lignans (which are 
more common in Western diets and derived from flaxseed, cereals and berries) and 
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isoflavones (derived from soya bean and its products). Interest in isoflavones arose 
when it was first noticed that the high rate of soy products consumed by Asian women 
seemed to correlate with a low breast cancer incidence. When these women migrated 
to the West, where soy consumption is not so entrenched, the breast cancer incidence 
equalled that of Western women within a few generations. Soy products have been the 
main focus of research activity because they are so structurally similar to human 
oestrogen. Depending on the researcher’s point of view, they are therefore considered 
either helpful in preventing the recurrence of cancer because they are capable of 
oestrogen receptor binding and blocking; or they are viewed as harmful because they 
can mimic the action of the naturally-produced oestrogens that are considered tumour-
promoting in a significant proportion of breast cancers (Duncan, 2004, Gold et al., 
2006, Hankinson and Eliassen, 2007, World Cancer Research Fund and American 
Institute of Cancer Research (WCRF/AICR), 2010).  
 
The results of studies of phyto-oestrogens mirror this controversy. Soy intake was 
modestly associated with a reduced risk of breast cancer in one pooled meta-analysis 
of cohort and case control studies comprising pre- and postmenopausal women (Trock 
et al., 2006). However, the authors of this meta-analysis expressed concerns that few 
studies included in the pool were originally designed to assess soy as a risk factor and 
they also noted inconsistent use of validated instruments. Additional evidence from a 
meta-analysis of later studies reported a dose-response relationship between soy 
intake and breast cancer prevention and concluded that the amount of soy intake 
typical of Asian populations could reduce breast cancer risk (Wu et al., 2008). In 
general, however, meta-analyses of all studies are limited because the studies they 
have pooled are so heterogeneous. For example, the measure of soy intake is rarely 
standardised and the differences in the type and quantity of soy consumed vary so 
widely among studies that it is difficult to reliably determine estimates of risk (World 
Cancer Research Fund and American Institute of Cancer Research (WCRF/AICR), 
2010). 
 
The situation with lignan is less confusing, mainly because relatively few studies have 
been conducted in this area. In vivo studies revealed that lignan might have preventive 
potential, but to date only one meta-analysis has found significant associations 
between lignan intake and breast cancer risk reduction in humans, particularly in 
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postmenopausal women (Velentzis et al., 2009, Bergman et al., 2007). As a result of 
the confusion surrounding phyto-oestrogens, the overall evidence is considered so 
limited that no conclusions about their anti-tumour effects can be made at present 
(World Cancer Research Fund and American Institute of Cancer Research 
(WCRF/AICR), 2010).  
 
Implications for women treated for breast cancer 
At present there is much conjecture and limited hard fact that plausibly explains how 
and why diet might be implicated in breast cancer recurrence. There are too many 
questions about the methodological reliability and validity of most of the research 
undertaken to date, with the issue further clouded by the complex, synergistic nature 
of food metabolism. Moreover, it is hard to locate good evidence that explicitly 
addresses the role of diet in cancer recurrence, as it is usually studied prospectively in 
women who have never been diagnosed with the disease. The only evidence of a 
causal relationship convincing enough for any international body to make dietary 
recommendations related to breast cancer pertains to first, alcohol consumption at any 
age; and second, to post-menopausal obesity arising from energy-dense food 
consumption that is excess to metabolic requirements. This evidence applies to 
women in general to prevent cancer, not specifically to women who have already had 
breast cancer.  
 
Nonetheless, our nursing research in this area indicates that many women treated for 
breast cancer are curious about the protective potential of diet and anxious for dietary 
advice that will help them maximise their health outcomes. Given the menopause-
inducing nature of many cancer treatments, and the oestrogen-sensitive nature of 
many breast tumours, all that can be said in relation to limiting the risk of recurrence 
is that women should probably minimise their consumption of alcohol to the level 
recommended by their relevant health authority, which in most Western countries is 
considered one standard measure of alcohol per day. Post-menopausal weight gain 
resulting from unnecessary consumption of fats and carbohydrates should also be 
avoided.   
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Multimodal cancer therapy is associated with numerous side effects from surgery, 
radiotherapy and systemic therapies such as ovarian failure, fatigue, cardiotoxicity, 
anaemia and bone loss (Montazeri, 2008). The scientific community recognises the 
important role of diet in preventing or managing some of these longer-term 
morbidities. Unlike recommendations to prevent cancer recurrence, the dietary 
evidence and the guidelines in this respect are unequivocal and firmly grounded in 
good evidence. Essentially, the dietary guidelines for the management of treatment 
toxicities are the same as those recommended for all women. A balanced diet is also 
considered generally protective of women with chronic conditions like breast cancer 
because the nature and proportions of nutrients it contains helps to maintain good 
cellular function; to mop up any damage caused by metabolic processes; and to 
maintain overall health. In terms of individual dietary components, the following 
strategies are therefore recommended (Food Standards Agency, 2010, National Health 
& Medical Research Council, 2003, World Health Organization, 2003, Dietitians 
Association of Australia, 2010, World Health Organization, 2004, World Cancer 
Research Fund and American Institute of Cancer Research (WCRF/AICR), 2010, 
Cancer Research UK, 2009): 
1. Limit fatty foods and simple sugar intake. This helps prevent excessive weight 
gain, moderates endogenous hormone levels and facilitates cardiovascular fitness. 
All fats and sugars are high in kilojoules, but some fats are essential and these 
should be regularly incorporated into the diet. These include polyunsaturated fats 
derived from plant and piscine sources that contain cardioprotective fatty acids 
such as omega-3 and omega-6.  
2. Eat plenty of fruit, vegetables, legumes and wholegrain cereals, which are 
important for several reasons. For example they contain fibre, which enhances 
feelings of satiety and therefore could help moderate fat intake. These foods are 
also abundant in the micronutrients vital for optimum cellular function and fatigue 
minimization. 
3. Include daily serves of lean red and white meats, fish or vegetarian sources of 
protein such as nuts and legumes. These nutrients are essential for the protein that 
helps maintain muscle strength and endurance; and the vitamin B12 that helps 
protect DNA. Equally important, lean meats are excellent sources of the iron that 
assists with fatigue reduction, cognitive function and resistance to infection in the 
context of breast cancer chronicity.  
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4. Low fat dairy products are essential for their contribution of calcium. The bone 
loss associated with treatment-induced menopause can be mediated with a high 
calcium intake from dairy foods when combined with adequate vitamin D 
obtained from sensible sun exposure or from other foods such as margarine, eggs, 
tuna and salmon. Due to the limited evidence base, recommendations relating to 
the amount of daily vitamin D intake cannot currently be made. 
5. Moderate alcohol intake. This limits exposure to oestrogen through excessive 
weight gain and the oestrogen-mimicking and carcinogenic metabolites of alcohol. 
It is recognised that one serve of alcohol daily could protect women at risk of 
cardiac disease. 
 
Implications for oncology nurses 
Education is a key factor with respect to enabling positive health behaviours such as 
dietary modification (Green and Kreuter, 2005), and oncology nurses are ideally 
placed to deliver it. However, preparing women for life after breast cancer treatment 
and advising them on the diet that will maximise their treatment outcomes is a 
complex business. Many issues related to the cancer itself require careful 
consideration – such as the hormone receptivity of the primary tumour; the nature of 
the treatment received; and the short- and long-term health outcomes that can be 
expected – because all of these factors can influence the specific dietary advice 
required. Coupled with this is attention to the demographic characteristics of the 
individual woman and her social circumstances. A woman’s dietary and educational 
needs are dynamic, highly individual and vary according to her phase in the cancer 
trajectory (Rees and Bath, 2001, Rutten et al., 2005). For example, research indicates 
that younger breast cancer patients have different educational needs to their older 
peers (Vivar and McQueen, 2005, Thewes et al., 2004, Beckjord et al., 2008). They 
tend to seek more information and base their search for information on a broader 
range of sources (Rutten et al., 2005). Similarly, it is not helpful to advise a woman 
who can barely afford her cancer treatment to eat salmon three days a week. The poor 
educational outcomes of neglecting such factors are often reported in the literature 
(Schmid-Buchi et al., 2008, Cappiello et al., 2007).  
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Women also describe problems with the content, timing and pedagogical aspects of 
the education they receive from health care staff in preparation for life after treatment. 
In the study we conducted in this field (Tramm, 2010, McCarthy et al., In review-a), 
women’s preferred educational preparation for dietary modification occurred in the 
period one or two months either side of treatment completion, when some sort of 
normality was re-established in their lives. It is plausible that dietary education is of 
little benefit while women are physically and emotionally distressed with the 
symptoms of active treatment during their first few cycles. Their memory can also be 
significantly affected by cytotoxic treatments and treatment-induced menopause 
during and after treatment (Cella and Fallowfield, 2008). Cognitive function should 
therefore be assessed before embarking on patient education and accounted for in both 
educational content and its method of delivery. Pedagogy is also important. Research 
indicates that people treated for cancer generally prefer oral group presentations by 
experienced peers and health professionals (Campbell et al., 2004, Rees and Bath, 
2000, Hoey et al., 2008), followed by written summaries and visual resources that 
account for differences in individual cognitive performance after treatment 
(McPherson et al., 2001).  
Conclusion 
This paper has reviewed the evidence about the role of diet after breast cancer 
treatment. While the evidence is largely inconclusive, three definite recommendations 
can be made and incorporated into educational programs: women at risk of breast 
cancer recurrence, or who experience co-morbidities as a result of treatment, should 
limit their exposure to alcohol; moderate their nutritional intake so that it does not 
contribute to post-menopausal weight gain; and partake of a balanced diet in 
accordance with international guidelines. Dietary education about these issues should 
ideally be individually-tailored, based on a good understanding of the international 
recommendations and the evidence underpinning them; in addition to a thorough 
assessment of the woman’s educational needs, their treatment outcomes and their 
specific social conditions to ensure their health outcomes are optimised. 
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